France Atrial Fibrillation Surgery Market Insight
Published: 16 June 2026 | Report Format: Electronic (PDF)
The France Atrial Fibrillation Surgery Market will grow at a rate of 6.72% due to aging population, rising burden of comorbidities, minimally invasive tech advancements, reimbursement & infrastructure, routine screening & early detection.
France Atrial Fibrillation Surgery Market Insights Forecasts to 2035
- The France Atrial Fibrillation Surgery Market Size Was Estimated USD 110.07 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 6.72%% from 2025 to 2035
- The France Atrial Fibrillation Surgery Market Size is Expected to rise around USD 210.96 Million by 2035
Notable Insights for the France Atrial Fibrillation Surgery Market
- Segmentation on the basis of Product Type indicates that catheter ablation segment holds 63% share in France AFib surgery market in 2025 due to minimally invasive procedures and technological advancements.
- Segmentation on the basis of Application indicates that catheter ablation segment dominates France AFib surgery market with 60–65% share in 2025 due to minimally invasive procedures, reimbursement, and PFA innovation.
- Over 1.5 million atrial fibrillation patients in France, part of 2 million arrhythmia cases, driving significant cardiac rhythm disorder burden.
- About 65% patients over 75 years, under 15% below 65, reflecting aging population and rising early-onset atrial fibrillation cases.
Download the eBook (ToC)
Why Buy This Report
- Offers precise market size, CAGR and revenue projections for the 2025-2035 timeframe, allowing participants to make informed investment decisions and business plans.
- Offers clear segmentation by procedure, technology, end user, whereby the participants can readily pinpoint high-growth opportunities within catheters and surgical ablations.
- Offers insights into the competitive scenario and innovation trends such as adoption of PFA, aiding organizations in benchmark analysis, positioning and estimation of future technology driven growth.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the France Atrial Fibrillation Surgery Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in France Atrial Fibrillation Surgery Market
- Medtronic
- Johnson & Johnson (Biosense Webster)
- Boston Scientific
- Abbott
- AtriCure
- Biotronik
- Philips
- Siemens Healthineers
- MicroPort EP
- CardioFocus
Recent Developments:
- In May 2025, Strengthened hospital partnerships for combined surgical-catheter approaches, improving long-standing persistent AF treatment outcomes by ~30% rhythm success rates.
- In February 2025, Integrated with CARTO 3 mapping system, improving lesion precision and supporting faster workflow in catheter ablation procedures.
Market Segmentation:
France Atrial Fibrillation Surgery Market, By Product
- Catheter Ablation
- Surgical Ablation
France Atrial Fibrillation Surgery Market, By Procedure
- Catheter Ablation
- Surgical/Maze Ablation
France Atrial Fibrillation Surgery Market, By End User
- Hospitals (largest share)
- Cardiac specialty centers
- Ambulatory surgical centers (growing segment)
- University & research hospitals
Expert Views:
The atrial fibrillation surgery market in France is growing consistently due to increased prevalence of arrhythmia, a growing aging population, and the rapid adoption of minimally invasive catheter ablation techniques. Emerging advancements in PFA devices and improved mapping technology is altering the efficiency of treatment. A favourable reimbursement scheme and well-established hospital infrastructure are enabling the market to thrive, with France establishing itself as an influential electrophysiology and cardiovascular innovation center.
Author: Govind and Krishna By Decisions Advisors and Consulting